Several inhibitors target V-type ATPases, affecting their catalytic activity. One well-known inhibitor is bafilomycin A1, which binds to the Vo domain and prevents proton translocation. Other inhibitors include concanamycin and archazolid. These inhibitors are valuable tools for studying the function of V-type ATPases and potential therapeutic agents for diseases involving dysregulation of these enzymes.
